Mayne Pharma Group Limited announced that Kathryn MacFarlane, PharmD, has accepted an invitation to join the Board of Mayne Pharma, effective 1 February 2022. The Company also announces that Ms Nancy Dolan will retire from the Board at the end of February 2022. Dr. MacFarlane, a US resident, has more than 30 years of experience in the pharmaceutical industry.

She is currently Founder and Managing Partner of SmartPharma LLC, offering commercial and strategic consulting services to pharmaceutical companies. Previously, she was Chief Commercial Officer at Agile Therapeutics, Vice President Women's Health Care Marketing, Sales and New Product Planning at Warner Chilcott and Senior Director of Marketing at Parke- Davis (now Pfizer). Ms Dolan has served as a Director of Mayne Pharma since September 2016 and is currently a member of the Audit and Risk Committee and the Nomination Committee.